1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32 | Continued from LIC 9099
Throughout the course of the investigation, LPAs reviewed all documents obtained and conducted medication audit. The following was then determined:
Regarding allegation of “Staff are not dispensing medication as prescribed” it was alleged that resident medications were not being administered as scheduled, and this has resulted in the resident exhibiting aggressive behavior towards others. Furthermore, the Responsible Party (RP) stated that staff have been crushing Resident #1’s (R1) medication without a physician’s prescription. Interviews conducted with morning Med-Techs staff revealed that there are currently no residents refusing medications. The Med-Tech assigned to the Meadows (Memory care unit) stated that approximately one month ago, R1 had changes to two (2) of their prescribed medications. Staff also stated that R1's medication is currently being administered in a crushed form. LORazepam 0.5 mg to be given as routine medication and not as a PRN and QUEtiapine (generic for Seroquel) changed from 25 mg to 50 mg on 07/17/2025. During the course of the investigation, LPAs conducted a medication audit and reviewed Centrally Stored Medication and Destruction Record (CSMDR), Medication Administration Records (MARs), physician’s orders and pill count for R1. The following was observed, medication QUEtiapine 25 mg, 1 tablet two (2) times a day at 8 AM and 8 PM and also give one (1) every 12 hours as needed, was filled and given for the first time on 08/04/2025 with a starting quantity of one hundred and twenty (120). At the time of the audit, one hundred and four (104) pills remained in the medication container for QUEtiapine 25 mg. Based on medication count and interview with Med-Tech, staff continued administering 25 mg medication instead of the 50 mg that was prescribed on 07/17/2025. Additionally, the documentation review revealed that LORazepam 0.5 mg recorded as being administered daily at 8 P.M. on both the CSMDR and the MARs. However, on the Controlled Drug Record, the same employee who initialed the MARs documented the administration time as 5 P.M. It is therefore inconclusive what time the medication was actually given. Furthermore, LPAs observed discrepancies in the documentation for Atorvastatin 40 mg. The refill date on the medication label was 05/17/2025 and the “opened date” recorded by staff was 05/05/2025.
Continued on LIC 9099-C
|